Flexion

FLXN NASDAQ
11.01
-0.63
-5.41%
交易中 14:04 06/24 EDT
开盘
11.59
昨收
11.64
最高
11.73
最低
10.97
成交量
47.38万
成交均量(3M)
61.34万
52周最高
27.84
52周最低
9.65
换手率
1.25%
市值
4.18亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Flexion FLXN股票价格,Flexion股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Flexion Therapeutics, Inc. is a United States-based specialty pharmaceutical company. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product candidate, Zilretta, is a late-stage, injectable, extended-release, intra-articular (IA) investigational steroid. The Company is developing Zilretta as a treatment for patients with moderate to severe OA knee pain. The Company has specifically designed Zilretta to combine a steroid, triamcinolone acetonide (TCA) with poly lactic-co-glycolic acid (PLGA), for providing sustained therapeutic concentrations in the joint and persistent analgesic effect. The Company's other product candidates include FX007 for post-operative pain and FX005 for the treatment of end-stage OA patients. The Company is engaged in conducting a Phase IIb clinical trial of Zilretta.
展开 >

最近浏览

名称
价格
涨跌幅